10x Genomics, Inc.
NASDAQ:TXG
15.64 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 151.654 | 153.104 | 141.006 | 183.979 | 153.644 | 146.819 | 134.285 | 156.232 | 131.072 | 114.609 | 114.496 | 143.53 | 125.297 | 115.842 | 105.821 | 112.218 | 71.817 | 42.905 | 71.905 | 75.289 | 61.207 | 55.819 | 53.578 | 50.554 | 36.607 | 31.744 | 29.576 |
| Cost of Revenue
| 45.261 | 46.208 | 45.437 | 77.914 | 58.115 | 47.207 | 35.895 | 36.827 | 30.377 | 27.704 | 25.478 | 27.597 | 24.518 | 4.915 | 17.06 | 18.897 | 14.411 | 10.052 | 15.108 | 16.582 | 15.48 | 15.006 | 13.965 | 14.9 | 5.241 | 4.55 | 4.26 |
| Gross Profit
| 106.393 | 106.896 | 95.569 | 106.065 | 95.529 | 99.612 | 98.39 | 119.405 | 100.695 | 86.905 | 89.018 | 115.933 | 100.779 | 110.927 | 88.761 | 93.321 | 57.406 | 32.853 | 56.797 | 58.707 | 45.727 | 40.813 | 39.613 | 35.654 | 31.366 | 27.194 | 25.316 |
| Gross Profit Ratio
| 0.702 | 0.698 | 0.678 | 0.577 | 0.622 | 0.678 | 0.733 | 0.764 | 0.768 | 0.758 | 0.777 | 0.808 | 0.804 | 0.958 | 0.839 | 0.832 | 0.799 | 0.766 | 0.79 | 0.78 | 0.747 | 0.731 | 0.739 | 0.705 | 0.857 | 0.857 | 0.856 |
| Reseach & Development Expenses
| 66.174 | 62.918 | 67.938 | 55.55 | 107.909 | 71.46 | 67.098 | 63.614 | 67.29 | 70.685 | 64.078 | 61.884 | 54.582 | 53.402 | 41.883 | 39.704 | 30.143 | 27.535 | 25.992 | 27.889 | 22.209 | 18.034 | 14.965 | 13.08 | 11.085 | 11.444 | 14.789 |
| General & Administrative Expenses
| 0 | 0 | 0 | 82.825 | 0 | 0 | 0 | 75.187 | 0 | 0 | 0 | 65.179 | 0 | 0 | 0 | 54.074 | 0 | 0 | 0 | 37.256 | 0 | 0 | 0 | 26.206 | 0 | 21.1 | 20.86 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 3.3 | 0 | 0 | 0 | 3.7 | 0 | 0 | 0 | 4.7 | 0 | 0 | 0 | 1.9 | 0 | 0 | 0 | 1.5 | 0 | 0 | 0 | 0.7 | 0 | 0.1 | 0.1 |
| SG&A
| 81.704 | 83.039 | 84.674 | 86.125 | 82.415 | 91.51 | 83.28 | 78.887 | 73.401 | 79.337 | 66.675 | 69.879 | 62.076 | 68.703 | 56.904 | 55.974 | 51.549 | 44.416 | 50.387 | 38.756 | 32.614 | 32.571 | 26.893 | 26.906 | 19.11 | 21.2 | 20.96 |
| Other Expenses
| 0.998 | -2.676 | -2.355 | 3.961 | -1.248 | -1.504 | -1.516 | 3.995 | -1.95 | -1.843 | -0.4 | 0.005 | -0.599 | 0.521 | -0.729 | 1.216 | 0.361 | -0.144 | -0.096 | 0.227 | -0.272 | 0.005 | -0.146 | -0.098 | -0.031 | 0 | 0 |
| Operating Expenses
| 147.878 | 148.633 | 154.967 | 141.675 | 190.324 | 162.97 | 150.378 | 142.501 | 140.691 | 150.022 | 130.753 | 131.763 | 116.658 | 122.105 | 98.787 | 95.678 | 81.692 | 71.951 | 76.379 | 66.645 | 54.823 | 50.605 | 41.858 | 39.986 | 30.195 | 32.806 | 35.809 |
| Operating Income
| -41.485 | -41.737 | -59.398 | -35.61 | -94.795 | -63.358 | -51.988 | -23.096 | -39.996 | -63.117 | -41.735 | -15.83 | -15.879 | -10.328 | -10.216 | -409.582 | -65.255 | -39.42 | -19.884 | -8.08 | -9.096 | -10.362 | -3.035 | -74.965 | -14.933 | -5.45 | -7.33 |
| Operating Income Ratio
| -0.274 | -0.273 | -0.421 | -0.194 | -0.617 | -0.432 | -0.387 | -0.148 | -0.305 | -0.551 | -0.365 | -0.11 | -0.127 | -0.089 | -0.097 | -3.65 | -0.909 | -0.919 | -0.277 | -0.107 | -0.149 | -0.186 | -0.057 | -1.483 | -0.408 | -0.172 | -0.248 |
| Total Other Income Expenses Net
| 7.047 | 4.658 | 1.595 | -10.988 | -1.248 | -1.504 | 2.334 | 6.685 | -0.039 | -0.714 | 0.041 | 0.005 | -0.599 | 1.371 | -0.919 | -406.009 | -40.608 | -0.466 | -1.919 | 0.085 | -0.272 | -0.565 | -0.936 | -70.731 | -16.135 | -0.457 | -3.464 |
| Income Before Tax
| -34.438 | -37.079 | -57.803 | -46.598 | -91.744 | -60.767 | -49.654 | -16.411 | -40.035 | -63.831 | -41.694 | -15.993 | -16.648 | -9.958 | -11.116 | -408.622 | -65.263 | -39.745 | -20.845 | -7.026 | -9.595 | -10.81 | -3.602 | -75.482 | -15.329 | -5.907 | -10.794 |
| Income Before Tax Ratio
| -0.227 | -0.242 | -0.41 | -0.253 | -0.597 | -0.414 | -0.37 | -0.105 | -0.305 | -0.557 | -0.364 | -0.111 | -0.133 | -0.086 | -0.105 | -3.641 | -0.909 | -0.926 | -0.29 | -0.093 | -0.157 | -0.194 | -0.067 | -1.493 | -0.419 | -0.186 | -0.365 |
| Income Tax Expense
| 1.315 | 0.818 | 2.146 | 2.354 | 1.242 | 1.647 | 1.093 | 0.804 | 1.879 | 0.627 | 0.719 | 2.456 | 0.523 | 1.094 | 0.435 | 6.95 | 0.585 | 0.422 | 0.298 | 0.108 | 0.008 | 0.068 | 0.034 | 0.042 | 0.016 | 0.016 | 0.015 |
| Net Income
| -35.753 | -37.897 | -59.949 | -48.952 | -92.986 | -62.414 | -50.747 | -17.215 | -41.914 | -64.458 | -42.413 | -18.449 | -17.171 | -11.052 | -11.551 | -415.572 | -65.848 | -40.167 | -21.143 | -7.134 | -9.603 | -10.878 | -3.636 | -75.524 | -15.345 | -5.923 | -10.808 |
| Net Income Ratio
| -0.236 | -0.248 | -0.425 | -0.266 | -0.605 | -0.425 | -0.378 | -0.11 | -0.32 | -0.562 | -0.37 | -0.129 | -0.137 | -0.095 | -0.109 | -3.703 | -0.917 | -0.936 | -0.294 | -0.095 | -0.157 | -0.195 | -0.068 | -1.494 | -0.419 | -0.187 | -0.365 |
| EPS
| -0.3 | -0.32 | -0.5 | -0.41 | -0.79 | -0.53 | -0.44 | -0.15 | -0.37 | -0.57 | -0.38 | -0.16 | -0.15 | -0.1 | -0.11 | -3.87 | -0.65 | -0.41 | -0.22 | -0.074 | -0.33 | -0.7 | -0.25 | -5.39 | -1.13 | -0.46 | -0.83 |
| EPS Diluted
| -0.3 | -0.32 | -0.5 | -0.41 | -0.79 | -0.53 | -0.44 | -0.15 | -0.37 | -0.57 | -0.38 | -0.16 | -0.15 | -0.1 | -0.11 | -3.87 | -0.65 | -0.41 | -0.22 | -0.074 | -0.33 | -0.7 | -0.25 | -5.39 | -1.13 | -0.46 | -0.83 |
| EBITDA
| -23.686 | -30.837 | -47.904 | -23.904 | -91.743 | -60.762 | -49.635 | -16.286 | -39.921 | -63.722 | -41.566 | -15.776 | -16.429 | -10.599 | -10.705 | -1.08 | -23.897 | -39.117 | -18.36 | -5.892 | -8.887 | -8.401 | -1.092 | -3.271 | 2.282 | -4.367 | -6.247 |
| EBITDA Ratio
| -0.156 | -0.201 | -0.34 | -0.13 | -0.597 | -0.414 | -0.37 | -0.104 | -0.305 | -0.556 | -0.363 | -0.11 | -0.131 | -0.091 | -0.101 | -0.01 | -0.333 | -0.912 | -0.255 | -0.078 | -0.145 | -0.151 | -0.02 | -0.065 | 0.062 | -0.138 | -0.211 |